If you are new to TikTikTalk ? Your first verification mail might be in your spam folder.Check there and move it to your inbox to complete registration or account verification process..
إعلان مُمول
sociofans

Cell & Gene Therapy Manufacturing Services Market worth $11.5 Billion

0
2كيلو بايت

The global cell & gene therapy manufacturing services market is expected to reach USD 11.5 billion by 2027, growing at a CAGR of 17.5% from 2022 to 2027. Growing prevalence of cancer and other other diseases, the surge in pharmaceutical R&D spending along with partnerships and agreements between pharmaceutical companies and CDMOs are some of the factors driving the market growth. On the contrary, the significant operational costs associated with cell and gene therapy manufacturing is expected to negatively impact the cell & gene therapy manufacturing market during the forecast period.

Request for Free Sample Report

Key Takeaways

  • The global cell & gene therapy manufacturing services market is expected to reach USD 11.5 billion by 2027, growing at a CAGR of 17.5% from 2022 to 2027.
  • The cell therapy segment dominated the cell & gene therapy manufacturing services market in 2021.
  • North America was the largest regional market for cell & gene therapy manufacturing services market in 2021.
  • Lonza (Switzerland), Catalent (US), Thermo Fisher Scientific (US), Charles River Laboratories (US), WuXi AppTec (China), Merck KGaA (Germany), Takara Bio Inc. (Japan), Oxford Biomedica (UK), Cell and Gene Therapy Catapult (UK) are some of the key players in the cell & gene therapy manufacturing services market.

Market Drivers

  • Growing prevalence of cancer and other other diseases
  • Surge in pharmaceutical R&D spending
  • Partnerships and agreements between pharmaceutical companies and CDMOs
  • Expansion of cell and gene therapy manufacturing capacities by CDMOs

Market Restraints

  • Significant operational costs associated with cell and gene therapy manufacturing
  • Stringent regulatory requirements
  • Lack of skilled professionals

Market Opportunities

  • Increasing demand for cell and gene therapies
  • Growing number of clinical trials for cell and gene therapies
  • Development of new cell and gene therapy technologies

Market Trends

  • Increasing adoption of cell and gene therapy manufacturing services by pharmaceutical and biotechnology companies
  • Growing focus on partnerships and collaborations between pharmaceutical companies and CDMOs
  • Expansion of cell and gene therapy manufacturing capacities by CDMOs

Geographical Analysis

  • North America was the largest regional market for cell & gene therapy manufacturing services market in 2021.
  • Europe is expected to be the second-largest market for cell & gene therapy manufacturing services market during the forecast period.
  • Asia Pacific is expected to be the fastest-growing market for cell & gene therapy manufacturing services market during the forecast period.

Company Profiles

  • Lonza (Switzerland)
  • Catalent (US)
  • Thermo Fisher Scientific (US)
  • Charles River Laboratories (US)
  • WuXi AppTec (China)
  • Merck KGaA (Germany)
  • Takara Bio Inc. (Japan)
  • Oxford Biomedica (UK)
  • Cell and Gene Therapy Catapult (UK)
  • Genezen (US)
  • FUJIFILM Holdings Corporation (Japan)
  • Nikon Corporation (Japan)
  • The Discovery Labs LLC (US)
  • RoslinCT (Scotland)
  • JRS Pharma (Germany)
  • FinVector (Finland)
  • ABL, Inc. (US)
  • Resilience (US)
  • BioCentriq (US)
  • Porton Advanced Solutions (China)
  • Andelyn Biosciences (US)
  • Forge Biologics (US)
  • Vibalogics (US)
  • Anemocyte Srl (Italy)
  • ElevateBio (US)

Speak to Analyst

Recent Developments

  • In 2021, Charles River Laboratories acquired a cell & gene therapy CDMO—Cognate BioServices—to increase its cell and gene therapy manufacturing capabilities.
  • In 2021, Thermo Fisher Scientific acquired Henogen S.A., Novasep's viral vector manufacturing business in Belgium, for approximately USD 859.7 million. This acquisition will increase its presence in the cell & gene therapy manufacturing therapy market.
  • In 2019, Thermo Fisher Scientific acquired Brammer Bio, a company engaged in viral vector manufacturing for gene and cell therapies, for USD 1.7 billion.

Top 10 Companies in the Tissue Diagnostics Market
Top 10 Companies in Human Capital Management Market
Top 10 Companies Leading the Patient Engagement Solutions Market
Top 10 Companies in the Blood Collection Devices Market

إعلان مُمول
إعلان مُمول
البحث
إعلان مُمول
الأقسام
إقرأ المزيد
Food
Bagel Boxes With Beautiful Decorative Ornaments
When it comes to bakeries, packaging is such a crucial piece of the puzzle when it comes to...
بواسطة sides 2025-01-14 04:29:35 0 769
أخرى
Operational Analytics Market Size, Share, Trends, Growth, and Forecast to 2030
The operational analytics market is expected to grow at a CAGR of 16.22% during the...
بواسطة Trending_Technology 2023-05-15 07:09:59 0 5كيلو بايت
أخرى
Green Construction Market Revenue Share Analysis, Market Growth Forecast, 2021–2032
The global Green Construction Market is forecasted to be worth USD 610.61 Billion by 2027,...
بواسطة vandanamanturgekar 2024-12-13 09:47:23 0 1كيلو بايت
أخرى
Business Process as a Service Market Global Industry Analysis, Opportunity Assessment and Forecast to 2030
Business Process as a Service Market Overview Business process as a service, or BPaaS, refers to...
بواسطة jeffwilson18 2023-04-20 04:56:34 0 4كيلو بايت
أخرى
Dolomite Market Share Will Hit USD 3.59 billion in 2030 | Says SNS Insider
Dolomite Market Overview: The most recent analysis will provide you with a thorough overview of...
بواسطة priti1 2023-10-10 14:16:18 0 4كيلو بايت
إعلان مُمول